Overview

The Private Equity (Lux) Evergreen Secondary Fund (ESF) aims to build a broadly diversified portfolio of Private Equity assets via secondary transactions.

Leveraging UBS’ global network and experience as a Private Equity investor for over 20 years, the strategy will target the entire secondary market to generate Private Equity returns.

ESF bridges the gap between traditional and alternative investments by providing investors with a quarterly liquidity option (subject to certain limitations).

Secondaries are investments in Private Equity funds that are typically three to seven years old with an existing portfolio of underlying companies, in contrast to primaries, which are investments in newly formed Private Equity funds.

Hence, secondaries effectively reduce the blind pool risk that is traditionally inherent in primary Private Equity investing, and accelerate the build-up of Private Equity exposure and the deployment of capital.

The exchange rate risk between EUR and USD is not hedged.

Benefits

Clients benefit from the experience, local capabilities and network of UBS SA国际传谋, Multi-Managers Private Equity with a track record of more than 23 years.

Clients are provided access to a diversified portfolio of Private Equity assets on a monthly basis via a fully paid-in structure with a quarterly liquidity option (subject to restrictions).

Secondaries allow a portfolio to be quickly diversified by investment strategy, sectors and vintage years with limited blind pool risk and J-curve effect.

Risks

The fund is tailored for investors with a longer term investment horizon and therefore the suitability of an investment into the fund needs to be duly considered in advance. The total allocation into Private Equity investments with restricted liquidity should be put into context of the client’s total bankable assets and risk appetite, as well as be consistent with the client's overall investment objectives and net worth. An examination of the prospectus and especially the terms and conditions is strongly advised prior to making a subscription or redemption into the fund. Prospective investors must be aware of the restricted liquidity to redeem any investment in the fund: redemption requests need to be communicated 90 calendar days prior to the actual redemption dealing day. The fund shall not redeem more than 5% of a share class’s assets on any given redemption dealing day. In case of excessive redemption requests on a redemption dealing day, all requests will be affected on a pro rata basis until the 5% limit is reached. The manager has the right to suspend redemptions in adverse market circumstances. This information reflects merely a summary of some of the fund’s aspects and risks. For detailed information, including the risks of investing, applicable fees and other important declarations, prospective investors are advised to request a copy of and read the full prospectus, in particular the risk section thereof. This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.

Features

Product category
UBS Private Equity Funds
Product domicile
Luxembourg
Portfolio management
UBS SA国际传谋 Switzerland AG, Zurich
Fund management
UBS SA国际传谋 (Europe) S.A., Luxembourg
Custodian bank
UBS Europe SE, Luxembourg Branch
Representative for products established under foreign law
UBS Europe SE, sucursal en España
Day of inception
November 30, 2022
Currency of account
USD
Close of financial year
December 31
SFDR Classification
Art.6
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
1.33% p.a.
Performance fee
10.00%
Management fee
0.96% p.a.
Minimum investment
n.a.
ISIN
LU2519447333
Bloomberg Ticker
PRVERUS LX

Performance and Prices

Percentage growth

as of February 28, 2026
Cumulative
USD(%) EUR(%)
YTD
1M
3M
6M
1Y
2Y 18.22 4.23
3Y 48.56 33.44
5Y
ø p.a.5Y

Structures

Fees

Ongoing costs p.a.
1.33%
Flat fee
n.a.
Management fee p.a.
0.96%
Max. issuing commission
0.00%
Max. redemption commission
0.00%
Distribution fee
(see info)

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Austria
Institutional Only*
Belgium
Institutional Only*
Denmark
Institutional Only*
Finland
Registered
France
Institutional Only*
Germany
Institutional Only*
Iceland
Institutional Only*
Ireland
Institutional Only*
Italy
Institutional Only*
Liechtenstein
Institutional Only*
Luxembourg
Registered
Netherlands
Institutional Only*
Norway
Registered
Portugal
Institutional Only*
Singapore
Institutional Only*
Spain
Institutional Only*
Sweden
Registered
Switzerland
Institutional Only*
United Kingdom
Institutional Only*

Literature

Brochures
Document type
Document Language
Fact Sheet
Private Equity Quarterly Portfolio Report
Fact Sheet - UBS Private Equity Funds
Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.